Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Nov 25;67(12):3104–3112. doi: 10.1002/art.39322

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Study design (A) and disposition of the study patients (B). ^aResponders according to the Clinical Disease Activity Index (CDAI) were defined as patients with a CDAI score of ≤10 or a 20% improvement over baseline. ^bResponders according to the Routine Assessment of Patient Index Data 3 (RAPID‐3) were defined as patients with a RAPID‐3 score of ≤6 or a 20% improvement over baseline. RA = rheumatoid arthritis; DMARD = disease‐modifying antirheumatic drug; TNF = tumor necrosis factor; DAS28‐ESR = Disease Activity Score in 28 joints using the erythrocyte sedimentation rate; LDA = low disease activity; CZP = certolizumab pegol; Q2W = every 2 weeks.